This inventor holds 1 USPTO granted patent and 10 published patent applications. Top assignees: Lawrence Livermore National Security, LLC, Leidos Biomedical Research, Inc., Theras, Inc.. Active years: 2026.
Company Filing History:
1 out of 1,621 
1 out of 4 
1 out of 1 Years Active: 2026
Title: Dhirendra Kumar Simanshu: Innovator in Cancer Treatment
Introduction
Dhirendra Kumar Simanshu is a notable inventor based in Frederick, MD (US). He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds aimed at treating cancers. His innovative work has led to the filing of a patent that addresses critical health challenges.
Latest Patents
Dhirendra Kumar Simanshu holds a patent for "Compositions and methods for inhibition of RAS." This patent includes compounds, salts, esters, tautomers, prodrugs, zwitterionic forms, or stereoisomers, along with pharmaceutical compositions that utilize these compounds. The methods described in the patent focus on modulating, specifically inhibiting, KRAS, particularly the KRAS G12C mutation. This innovation is aimed at treating various diseases or disorders, including cancers, in patients who require such interventions.
Career Highlights
Throughout his career, Dhirendra has worked with reputable organizations such as Theras, Inc. and Leidos Biomedical Research, Inc. His experience in these companies has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Dhirendra has had the opportunity to work alongside talented individuals, including David Turner and Tao Liao. These collaborations have enriched his research and have been instrumental in advancing his innovative projects.
Conclusion
Dhirendra Kumar Simanshu is a distinguished inventor whose work in cancer treatment through innovative compounds and methods showcases his commitment to improving healthcare. His contributions are paving the way for new therapeutic options in the fight against cancer.